American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Merck & Co., Inc. (MRK)

$140.61 -3.21% NYSE: MRK · 15-min delayed

RAHWAY, New Jersey
Public · NYSE: MRK
75,000 employees

Visit website Follow

$323.7BMarket cap

$65.0BRevenue · FY2025

$18.3BNet income

75,000Employees

MRKNYSE

1949IPO

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NYSE: MRK
Employees: 75,000
IPO date: Apr 20, 1949
Headquarters: 126 EAST LINCOLN AVENUE
RAHWAY, New Jersey 07065
Phone: 908-740-4000
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: NJ, United States
Registered office: Trenton, US
Legal entity ID: 4YV9Y5M8S0BRK1RP0397

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Is Merck & Co., Inc. an American company? Yes. Merck & Co., Inc. is incorporated in New Jersey, United States and headquartered in Rahway, New Jersey. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Registry IDs

Ticker: MRK NYSE
SEC CIK: 310158
LEI: 4YV9Y5M8S0BRK1RP0397
EIN: 221918501
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Merck & Co., Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/merck-co-inc/"><img src="https://americancompanies.com/badge/merck-co-inc.svg" alt="Merck & Co., Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Merck & Co., Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $65.0B
Net income: $18.3B
Total assets: $136.9B
Market cap: $323.7B

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: MRK

$140.61 -3.21%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$77.60 $156.45

52-week range

Market cap: $323.7B
Dividend yield: 2.42%
Shares outstanding: 2.3B
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Apr 20, 1949

Merck & Co., Inc. (MRK) Stock Price

Profitable — net income of $18.3B in FY2025.
Trading 10% below its 52-week high.
Pays a dividend yielding about 2.42% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

PFIZER INCPFE

Moderna, Inc.MRNA

ELI LILLY & CoLLY

AbbVie Inc.ABBV

GILEAD SCIENCES, INC.GILD

BRISTOL MYERS SQUIBB COBMY

No reviews yet. Be the first to review Merck & Co., Inc..

Write a review

Newsroom

News about Merck & Co., Inc.

AC Original Is Merck & Co., Inc. an American Company? Here's the Answer Yes — Merck is headquartered in New Jersey, listed on the NYSE since 1949, and generates nearly half its sales from US … Aug 1, 2026

News House Committee Investigates Merck (MRK), AbbVie (ABBV) Trials Merck stock trades near its 52 week high at 128.5 dollars as lawmakers probe its China clinical trials. See what the P/… Jul 1, 2026

Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings? Zacks Investment Research · 2026-10-26 · positive Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH? The Motley Fool · 2026-10-26 · neutral Breakfast News: Science Strikes Back at Cancer The Motley Fool · 2026-10-26 · neutral Is First Trust Capital Strength ETF (FTCS) a Strong ETF Right Now? Zacks Investment Research · 2026-10-26 · neutral Microbiotica Presents Phase 1b Clinical Data on MB097 at the European Society for Medical Oncology (ESMO) Congress 2026 GlobeNewswire Inc. · 2026-10-26 · neutral Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy? The Motley Fool · 2026-10-24 · neutral

News & sentiment via Polygon.io

FAQ

Merck & Co., Inc.: frequently asked questions

Is Merck & Co., Inc. an American company?

Yes — Merck & Co., Inc. is an American company. Merck & Co., Inc. is incorporated in New Jersey, United States and headquartered in Rahway, New Jersey. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Merck & Co., Inc. incorporated?

Merck & Co., Inc. is legally incorporated in New Jersey, United States, according to its GLEIF legal-entity record.

Who owns Merck & Co., Inc.?

Merck & Co., Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Merck & Co., Inc. traded on a US stock exchange?

Yes — Merck & Co., Inc. trades under the ticker MRK on the NYSE.

Where is Merck & Co., Inc. headquartered?

Merck & Co., Inc. is headquartered in Rahway, New Jersey, United States.

Is Merck & Co., Inc. publicly traded?

Yes — Merck & Co., Inc. is a publicly traded company. Its stock trades under the ticker symbol MRK on the NYSE.

What does Merck & Co., Inc. do?

Merck & Co., Inc. is an American Pharmaceuticals company in the Health & Beauty sector.